Published February 2021 | Version v1
Journal article

Biofabrication of poly(l-lactide-co-ε-caprolactone)/silk fibroin scaffold for the application as superb anti-calcification tissue engineered prosthetic valve

  • 1. Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192 (China)
  • 2. Tianjin Enterprise Key Laboratory for Application Research of Hyaluronic Acid, Tianjin 300385 (China)
  • 3. Key Laboratory of Bioactive Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, College of Life Science, Nankai University, Tianjin 300071 (China)

Description

Highlights: • A PLCL/SF electrospun scaffolds was fabricated and its feasibility as TEHV materials has been verified. • The PLCL/SF electrospun scaffolds exhibited excellent mechanical and anti-calcification properties. • Compared with clinically used porcine pericardium, the calcification level of PLCL/SF electrospun scaffolds was much lower. • All these above results indicated great potential of PLCL/SF electrospun scaffolds used in the field of TEHV materials. In this study, electrospun scaffolds were fabricated by blending poly(l-lactide-co-ε-caprolactone) (PLCL) and silk fibroin (SF) with different ratios, and further the feasibility of electrospun PLCL/SF scaffolds were evaluated for application of tissue engineered heart valve (TEHV). Scanning electron microscopy (SEM) results showed that the surface of PLCL/SF electrospun scaffolds was smooth and uniform while the mechanical properties were appropriate as valve prosthesis. In vitro cytocompatibility evaluation results demonstrated that all of the PLCL/SF electrospun scaffolds were cytocompatible and valvular interstitial cells (VICs) cultured on PLCL/SF scaffolds of 80/20 & 70/30 ratios exhibited the best cytocompatibility. The in vitro osteogenic differentiation of VICs including alkaline phosphatase (ALP) activity and quantitative polymerase chain reaction (qPCR) assays indicated that PLCL/SF scaffolds of 80/20 & 90/10 ratios behaved better anti-calcification ability. In the in vivo calcification evaluation model of rat subdermal implantation, PLCL/SF scaffolds of 80/20 & 90/10 ratios presented better anti-calcification ability, which was consistent with the in vitro results. Moreover, PLCL/SF scaffolds of 80/20 & 70/30 ratios showed significantly enhanced cell infiltration and M2 macrophage with higher CD206+/CD68+ ratio. Collectively, our data demonstrated that electrospun scaffolds with the PLCL/SF ratio of 80/20 hold great potential as TEHV materials.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.msec.2021.111872

Additional details

Identifiers

DOI
10.1016/j.msec.2021.111872;
PII
S0928493121000102;

Publishing Information

Journal Title
Materials Science and Engineering. C, Biomimetic Materials, Sensors and Systems
Journal Volume
121
Journal Page Range
vp.
ISSN
0928-4931

Optional Information

Copyright
Copyright (c) 2021 Elsevier B.V. All rights reserved.